42 participants
A Study of Donanemab (LY3002813) in Healthy Participants
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-04
- Start Date:
- 2022-10-04
- Completion:
- 2023-07-14
Conditions
- Healthy
Interventions
- DRUG